Skip to main content
Top
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

Primary ductal carcinoma in situmammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways

Authors: G Farnie, K Spence, K Brennan, NJ Bundred, RB Clarke

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

The cancer stem cell hypothesis suggests that targeting stem-like cells in cancer will improve current therapeutic strategies. In vitro culture of mammospheres (MS), colonies that are analogous to neurospheres, has been used to study factors affecting the self-renewal and growth of ductal carcinoma in situ (DCIS) in 29 cases. The MS culture system demonstrates a small subset of DCIS cells with self-renewal clonogenic capacity showing 1.5 ± 0.1% MS forming efficiency (MFE), which is greater than normal breast MFE, 0.5 ± 0.1% (P < 0.0001). DCIS MS demonstrated an increased growth rate compared with normal, yielding MS > 60 μm within 3 days rather than 7 days. The MFE was greater in high (1.6 ± 0.1%) compared with low (1.1 ± 0.1%, P = 0.012) histological grade DCIS, suggesting a link between the number of MS-initiating cells and recurrence rates. …
Metadata
Title
Primary ductal carcinoma in situmammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways
Authors
G Farnie
K Spence
K Brennan
NJ Bundred
RB Clarke
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1978

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine